Biotech Strategy Blog

Commentary on Science, Innovation & New Products with a focus on Oncology, Hematology & Cancer Immunotherapy

  • Conferences
    • AACR19
    • AACR18
    • AACR17
    • AACR16
    • AACR15
    • AACR14
    • AACR IO
    • AAI ASGCT
    • ASCO GI
    • ASCO GU
    • ASCO-SITC
    • ASCO19
    • ASCO18
    • ASCO17
    • ASCO16
    • ASCO15
    • ASCO14
    • ASH19
    • ASH18
    • ASH17
    • ASH16
    • ASH15
    • AUA
    • BMT
    • CIML40
    • CIMT
    • EACR
    • EAU
    • ECCO
    • ESMO19
    • ESMO18
    • ESMO17
    • ESMO16
    • ESMO14
    • JPM20
    • SABCS
    • SITC 2019
    • SITC 2018
    • SITC 2017
    • SITC 2016
    • SITC 2015
    • SITC 2014
    • Targets19
  • Targets
    • Bispecifics
    • Cytokines
    • MYC
    • Neoantigens
    • RAS
    • STING
  • About
  • Contact
  • Pricing
  • Podcast
  • Premium Content
  • Immuno-Oncology
  • Cell Therapy
  • Interviews
  • Login

  • Overcoming challenges associated with cell therapy approaches

    Read more

  • A hidden gem in the KRAS niche

    Read more

  • Competition rapidly heats up in the KRAS space!

    Read more

  • Update on the KRAS Runners and Riders

    Read more

  • What do we learn from a first look at Mirati’s KRAS G12C inhibitor MRTX849?

    Read more

  • A novel approach to targeting BRAF and KRAS mutant cancers

    Read more

  • Update on Amgen’s KRAS inhibitor in solid tumours

    Read more
E

Overcoming challenges associated with cell therapy approaches

Insights from Transplantation & Cellular Therapy (TCT) meeting on the next generation of CAR T cells

View post
E

A hidden gem in the KRAS niche

Attention on small molecule inhibitors – after being in the…

View post
E

New developments in Genitourinary cancers

Highlights from ASCO GU 2020 with some interesting targets and emerging molecules to consider

View post

Terms of Use & Privacy Policy
Copyright © 2010-20 Biotech Strategy Blog

Free Email Updates
Subscribe to new post alerts, offers, and additional content!
We respect your privacy and do not sell emails. Unsubscribe at any time.
error: Content is protected !!